Skip to content

Increased Inflammation-resolving Activity by Omega-3 Monoglycerides in Peripheral Blood Mononuclear Cells (PBMC).

Resolution of Inflammation | Reduction of Cell Proliferation

The purpose of this biological study is to provide Dr. Samuel Fortin's laboratory with a continuous supply of blood mononuclear cells (PBMCs) so that he can pursue research on the potential beneficial effects of monoglyceride omega-3 fatty acids on the resolution of inflammation.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* Participant aged of at least 18 years old.

Exclusion Criteria:

* Participant who use omega-3 supplements and / or anti-inflammatory medication such as, but not limited to - Aspirin, Ibuprofen (Motrin, Advil), Celecoxib (Celebrex), diclofenac (Cambia, Cataflam, Voltaren ) within 7 days of day 1 of the study.

Lieu de l'étude

SCF Pharma
SCF Pharma
Rimouski, Quebec
Canada

Contactez l'équipe d'étude

Primary Contact

Samuel Fortin, PhD

[email protected]
418-750-8590
Étude parrainée par
SCF Pharma
Participants recherchés
Plus d'informations
ID de l'étude: NCT05161702